This article was originally published in The Tan Sheet
Jim Peters brings "experience with countless merger and acquisition transactions" to his new role as a member of Natrol's Board of Directors, the firm announces July 5. The company is "focused upon strategic acquisitions and partnerships as a key component of our growth strategy," Executive Chairman Elliott Balbert says. Natrol expects that Peters will be named chairman of the audit committee. He is a retired partner in the audit practice of Ernst & Young...
You may also be interested in...
Health technology assessment body NICE has now recommended that selective internal radiation therapy can be used on England’s National Health Service for treating advanced liver cancer.
A “structured dialog” led by the European Commission with pharmaceutical industry stakeholders provides a critical opportunity to address weaknesses in the stability and security of the supply chain by improving the environment for local manufacturing, Medicines for Europe believes.
Despite a slight increase in revenue, South Africa’s Adcock continues to struggle as it reports a continued drop in gross profit. The company expects the economy to remained constrained due to COVID-19, but is eagerly anticipating recovery with the government’s vaccine roll-out.